| [1] |
Lyu Chang, Zhou Liming.
Correlation between the TNF-α-308 gene polymorphism and gastric cancer susceptibility: A meta-analysis
[J]. Clinical Focus, 2023, 38(9): 779-787.
|
| [2] |
Feng Xiongcai, Huo Lijuan.
Furazolidone-containing quadruple therapy for Helicobacter pylori:A case report of severe adverse reactions
[J]. Clinical Focus, 2022, 37(6): 548-550.
|
| [3] |
Guo Hao, Zhuang Huicui, Yang Limei, Ren Jing, Cui Dongsheng, Zhang Liran.
2019-2021 pathogen infection characteristics and drug resistance analysis on patients from Intensive Care Unit of the Hospital
[J]. Clinical Focus, 2022, 37(6): 519-524.
|
| [4] |
Zhu Ying, Shu Qianqian, Chen Fuhui.
Clinical characteristics and drug resistance of community-acquired Acinetobacter baumannii pneumonia
[J]. Clinical Focus, 2022, 37(4): 315-319.
|
| [5] |
Huang Yehong, Liu Gaifang, Xin Chenxi, Zhao Yunhong, Wu Jing.
Searching for an optimal therapy for H.pylori eradication: High-dose proton-pump inhibitor dual therapy vs. bismuth-containing quadruple therapy
[J]. Clinical Focus, 2022, 37(3): 230-233.
|
| [6] |
Yu Jinghong, Zhao Yan, Yu Shufeng, Wang Caixia.
Investigation and analysis on helicobacter pylori infection of children in Qingdao region
[J]. Clinical Focus, 2022, 37(2): 141-144.
|
| [7] |
Li Shufan, Wang Yuxiu, Jiang Zhenghua.
The correlation between the prognosis of lung adenocarcinoma with acquired resistance to the first-generation EGFR TKI and the T790M mutation
[J]. Clinical Focus, 2022, 37(11): 985-991.
|
| [8] |
Peng Zhenli, Jiang Yao, Jia Lijuan, Wang Yanxin, Xue Weixiao, Shi Huiting.
Analysis of pathogenic bacteria resistance and prognosis of bloodstream infection
[J]. Clinical Focus, 2021, 36(8): 724-729.
|
| [9] |
Jin Ying, Wang Pai, Feng Shibing.
Application value of Helicobacter pylori, PG and G17 in diagnosing precancerous lesions of gastric cancer
[J]. Clinical Focus, 2021, 36(3): 233-237.
|
| [10] |
Shen Ziyuan, Kang Haiquan, Sang Wei, Yan Dongmei.
Analysis of bacterial distribution, resistance and risk factor of death of bacterial infection in leukemia patients
[J]. Clinical Focus, 2021, 36(12): 1092-1096.
|
| [11] |
Lu Tao1, Ni Li1, Seto Waikay1, 2, Liu Jun3, Guo Haijian3, Wu Jianwei4, Lu Zhiwu4, Li Yinpeng5, Yang Qiu5, Yu Xiqiu6.
A multicenter study of antibiotic resistance characteristics of Helicobacter pylori in Shenzhen
[J]. Clinical Focus, 2020, 35(8): 714-718.
|
| [12] |
Li Xiaa, Ma Gaoxib, Hu Linglingc，Dong Fengmeib.
Distribution and drug resistance of Streptococcus pneumoniae infection in children
[J]. Clinical Focus, 2020, 35(2): 170-173.
|
| [13] |
Yin Haiqing1a, Yao Baoguo2a, Chen Wanzhen1b, Su Li2b.
Risk factors and drug resistance of Carbapenemresistant Enterobacter in malignant tumor patients
[J]. Clinical Focus, 2020, 35(2): 166-169.
|
| [14] |
Shi Youshan, Chen Tianhao.
Pathogenic bacteria and etiological analysis of peritoneal dialysisassociated peritonitis in a single peritoneal dialysis center
[J]. Clinical Focus, 2020, 35(11): 1010-1014.
|
| [15] |
Tian Lihua1, Xue Yanan2, Tu Qiang2, Xu Xiuying3.
Effect of Helicobacter pylori infection on chronic complications in patients with type 2 diabetes
[J]. Clinical Focus, 2019, 34(5): 436-440.
|
